Helsinki Ultra-acute Stroke Biomarker Study


Phase N/A Results N/A

Summary of Purpose

The aim of this study is to establish diagnostic and predictive biomarkers for patients with suspected acute stroke, that are transported by EMS as candidates for thrombolytic treatment. The study focuses on the ultra acute phase, <4.5 hours from symptom onset, including the prehospital setting. Analyses will include known biomarkers (e.g. GFAP, NR2 peptide) and a discovery phase for novel markers. Patient...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 31 March 2016.

1 May 2013 2 May 2014 1 Feb 2016 Unavailable 1 Mar 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Case-Only
  • Perspective: Prospective
  • Sampling: Probability Sample


  • Perttu Lindsberg, MD, PhD